Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities. CBL's owned and managed portfolio is comprised of 94 properties totaling 58.5 million square feet across 22 states, including 56 high-quality enclosed malls, outlet centers and lifestyle retail centers as well as more than 30 open-air centers and other assets. CBL seeks to continuously strengthen its company and portfolio through active management, aggressive leasing and profitable reinvestment in its properties.

CBL & Associates Properties, Inc.

Raymond James analyst maintained a Buy rating on Ceribell, Inc. today and set a price target of $29.00. Ceribell, Inc. has an analyst consensus of ...

Ceribell, Inc. (CBLL) Gets a Buy from Raymond James

An update from Control Bionics Ltd. ( ($AU:CBL) ) is now available. Control Bionics director Stephen Rix has increased his holding in the company t...

Control Bionics Director Stephen Rix Increases Shareholding

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Ltd., listed on the ASX under ticker CBL, is a developer of assistive comm...

Control Bionics sets cautious tone as it shifts from repositioning to growth

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited has lodged its latest corporate governance statement for the year ...

Control Bionics Files Updated ASX Corporate Governance Statement

The latest announcement is out from Control Bionics Ltd. ( ($AU:CBL) ). Control Bionics Limited’s latest annual report outlines a unified platform ...

Control Bionics Sets Growth Agenda Around Unified Assistive Tech Platform

Control Bionics Ltd. ( ($AU:CBL) ) has issued an update. Control Bionics Limited reported a 22.4% decline in revenues from ordinary activities to $...

Control Bionics Posts Wider Loss as It Takes Full Control of U.S. Neurotech Unit

Control Bionics Ltd. ( ($AU:CBL) ) has shared an announcement. Control Bionics Limited will release its financial results for the full year ended 3...

Control Bionics to unveil FY26 results with investor webcast

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics has secured U.S. Medicare PDAC coding verification for two UnoTouch Omni s...

Control Bionics Wins Key U.S. Medicare Code for UnoTouch Omni Speech Devices

Clear Blue Technologies International ( ($TSE:CBLU) ) has provided an announcement. Clear Blue Technologies reported Q2 2026 results showing strong...

Clear Blue Technologies Narrows Losses and Targets H2 2026 Revenue Growth

An update from Control Bionics Ltd. ( ($AU:CBL) ) is now available. Control Bionics Limited has secured registration from the UK Medicines and Heal...

Control Bionics wins UK approval for NeuroStrip, advancing international expansion

The latest update is out from PCBL Chemical Limited ( ($IN:PCBL) ). PCBL Chemical Limited has appointed Rohit Maindwal as Chief and Executive Direc...

PCBL Chemical Names Rohit Maindwal Executive Director for Specialty Blacks

China BlueChemical ( ($HK:3983) ) just unveiled an announcement. China BlueChemical reported interim revenue of RMB5,619 million for the six months...

China BlueChemical Posts Solid Interim Profit Despite Higher Impairment Charges

Ceribell, Inc. (($CBLL)) has held its Q2 earnings call. Read on for the main highlights of the call. Ceribell’s latest earnings call painted a pict...

Ceribell Earnings Call Highlights Growth Over Profits

The latest announcement is out from Control Bionics Ltd. ( ($AU:CBL) ). Control Bionics Limited has notified the market of the issue of 2,333,331 u...

Control Bionics Issues New 2026 ESOP Options to Staff

The latest announcement is out from Control Bionics Ltd. ( ($AU:CBL) ). Control Bionics Ltd. has applied to the ASX for quotation of 97,771,039 new...

Control Bionics Seeks ASX Quotation for Nearly 98 Million New Shares

Companies in the NA sector have received a lot of coverage today as analysts weigh in on Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Thera...

Analysts’ Opinions Are Mixed on These NA Stocks: Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Therapeutics (ARCT) and Ceribell, Inc. (CBLL)

Companies in the NA sector have received a lot of coverage today as analysts weigh in on Rapid7 (RPD) and Ceribell, Inc. (CBLL). Rapid7 (RPD) In a ...

Analysts Offer Insights on NA Companies: Rapid7 (RPD) and Ceribell, Inc. (CBLL)

Control Bionics Ltd. ( ($AU:CBL) ) has provided an update. Control Bionics Ltd. has notified the market of the issue of 1,250,000 unquoted options ...

Control Bionics Grants 1.25 Million Options to Non‑Executive Director

There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Ceribell, Inc. (CBLL) and Janus Living, Inc. Class A (JAN) w...

Analysts Offer Insights on NA Companies: Ceribell, Inc. (CBLL) and Janus Living, Inc. Class A (JAN)

Control Bionics Ltd. ( ($AU:CBL) ) has shared an announcement. Control Bionics Limited reported the outcomes of a 6 August 2026 security holder mee...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CBL	$54.98	+0.11%	117.68K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CBL	$54.98	+0.1%	117.68K
3
4
5
6

CBL

Get CBL & Associates Properties, Inc. Data in Excel

Get CBL & Associates Properties, Inc. Data in Excel